-
Firefly Luciferase mRNA: Workflow & Optimization
2026-09-17
Firefly Luciferase mRNA (ARCA, 5-moUTP) provides a sensitive, transient readout for delivery, expression, viability, and imaging studies. This workflow-focused guide shows how to handle the transcript, design controls, evaluate freeze–thaw effects in lipid nanoparticles, and troubleshoot weak or variable bioluminescence.
-
Epalrestat and Polyol Flux in Cancer Research
2026-09-16
Epalrestat is an aldose reductase inhibitor that enables a more precise way to study polyol-pathway flux, fructose metabolism, and oxidative stress. This article presents an assay-centered framework that separates metabolic mechanism from downstream cancer phenotypes while defining translational limits.
-
Reporter mRNA as a Translation Strategy
2026-09-16
A mechanistic and strategic guide to using firefly luciferase mRNA as a benchmark for translation, delivery, biodistribution, and translational decision-making.
-
Sodium dicloxacillin monohydrate: Assay Guide
2026-09-15
This scenario-driven guide explains how Sodium dicloxacillin monohydrate, SKU C8716, can support controlled Gram-positive infection and cell-viability workflows without confusing antibacterial activity with direct mammalian cytotoxicity. It combines product benchmarks, pH-aware experimental design, analytical-method cautions, and practical vendor-selection criteria.
-
nor-Binaltorphimine dihydrochloride in KOR Assays
2026-09-15
Use nor-Binaltorphimine dihydrochloride to test whether κ-opioid receptor signaling is necessary for opioid-driven changes in cellular, spinal, or behavioral readouts. This guide connects a recent brain-to-spinal pain study with practical antagonist assay design, formulation controls, and troubleshooting strategies.
-
Talin1–Piezo1–YAP Axis in Atherosclerosis
2026-09-14
A 2026 study identifies Talin1 as a mechanistic regulator linking Piezo1-mediated calcium influx to YAP-dependent endothelial inflammation. Using atherosclerotic mice and disturbed-flow endothelial models, the work positions Talin1 as a potential target for dissecting vascular inflammation rather than merely a plaque-associated marker.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-09-14
Explore how the JC-1 Mitochondrial Membrane Potential Assay Kit converts mitochondrial polarization into a ratiometric readout for apoptosis assay design and mitochondrial function analysis. This guide connects ΔΨm measurement with mechanistic insights from recent gold(I)-based cancer immunomodulation research while defining the assay’s practical limits.
-
ARCA EGFP mRNA as an LNP Decision Tool
2026-09-13
ARCA EGFP mRNA can function as more than a fluorescent control: it is a practical diagnostic for separating delivery, intracellular release, and translation in mammalian cells. This article connects reporter design with lipid nanoparticle assay decisions and interprets findings from a macrophage-delivery study.
-
Epalrestat: A Metabolic Lens for Cancer Assays
2026-09-12
Epalrestat is an aldose reductase inhibitor that can help researchers distinguish endogenous polyol-pathway fructose production from imported fructose in cancer metabolism assays. This article presents a mechanistic, control-driven framework linking metabolic flux, oxidative stress, and pathway interpretation.
-
C34 TLR4 Inhibitor: From Signal to Assay
2026-09-11
C34 is a selective TLR4 inhibitor for testing LPS-driven inflammatory signaling in macrophages, enterocytes, and related models. This article develops a cross-model framework that uses C34 to distinguish pathway causality from correlation, including insights from recent Taxus chinensis neuroinflammation research.
-
2-APB Workflow for ER Calcium Signaling
2026-09-11
2-APB enables practical dissection of IP3R-mediated calcium release, store-operated calcium entry, and downstream autophagy–apoptosis decisions. This workflow connects live Ca2+ imaging with calpain, LC3-II, ATG5, and caspase-3 readouts while addressing the compound’s concentration-dependent selectivity limits.
-
EZ Cap™ OVA mRNA Workflow Guide
2026-09-10
Use EZ Cap™ OVA mRNA to build controlled antigen-expression workflows for immune response immunogen studies, airway hyperreactivity models, and vaccine development research. This guide connects Cap 1 transcript design with delivery-system selection, quantitative controls, and practical troubleshooting.
-
Carbapenemase Gene Spread in Enterobacter cloacae
2026-09-10
Chen et al. integrate gene localization, conjugation, mobile-element analysis, and strain typing to investigate carbapenemase dissemination in carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The findings identify frequent blaNDM-1 carriage, efficient transfer of carbapenemase-encoding genes, and substantial multidrug resistance, while also showing why plasmid mobility and clonal relatedness must be interpreted together.
-
Pol II Degradation and Transcription-Independent Cell Death
2026-09-09
The bioRxiv preprint argues that degrading RNA polymerase II activates cell death through a mechanism that cannot be explained solely by the resulting loss of transcription. Its central contribution is a causal distinction between transcriptional shutdown and depletion of the Pol II protein complex, with implications for mechanistic cancer biology research and interpretation of transcription-targeting compounds.
-
BFH772 (VEGFR2 inhibitor): Workflow Guide
2026-09-09
BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of VEGFR2-dependent signaling and angiogenesis. Its water insolubility and organic-solvent compatibility make it unsuitable for direct aqueous stock preparation, while the reported biochemical potency should not be treated as a universal cellular working concentration.